Performance of bleeding risk scores in dialysis patients

被引:33
|
作者
Ocak, Gurbey [1 ]
Ramspek, Chava [2 ]
Roolunaaker, Maarten B. [1 ]
Blankestijn, Peter J. [1 ]
Verhaar, Marianne C. [1 ]
Bos, Willem Jan W. [3 ]
Dekker, Friedo W. [2 ]
van Diepen, Merel [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands
[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[3] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
关键词
ATRIA; dialysis; HASBLED; HEMORR2HAGES; ORBIT; HAS-BLED SCORE; ATRIAL-FIBRILLATION; ANTICOAGULATED PATIENTS; HEMODIALYSIS-PATIENTS; CHA(2)DS(2)-VASC SCORES; MULTIPLE IMPUTATION; WARFARIN INITIATION; PREDICTIVE ABILITY; ISCHEMIC-STROKE; HEMORRHAGE;
D O I
10.1093/ndt/gfy387
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Bleeding risk scores have been created to identify patients with an increased bleeding risk, which could also be useful in dialysis patients. However, the predictive performances of these bleeding risk scores in dialysis patients are unknown. Therefore, the aim of this study was to validate existing bleeding risk scores in dialysis patients. Methods A cohort of 1745 incident dialysis patients was prospectively followed for 3 years during which bleeding events were registered. We evaluated the discriminative performance of the Hypertension, Abnormal kidney and liver function, Stroke, Bleeding, Labile INR, Elderly and Drugs or alcohol (HASBLED), the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA), the Hepatic or kidney disease, Ethanol abuse, Malignancy, Older age, Reduced platelet count or Reduced platelet function, Hypertension, Anaemia, Genetic factors, Excessive fall risk and Stroke (HEMORR2HAGES) and the Outcomes Registry for Better Informed Treatment (ORBIT) bleeding risk scores by calculating C-statistics with 95% confidence intervals (CI). In addition, calibration was evaluated by comparing predicted and observed risks. Results Of the 1745 dialysis patients, 183 patients had a bleeding event, corresponding to an incidence rate of 5.23/100 person-years. The HASBLED [C-statistic of 0.58 (95% CI 0.54-0.62)], ATRIA [C-statistic of 0.55 (95% CI 0.51-0.60)], HEMORR2HAGES [C-statistic of 0.56 (95% CI 0.52-0.61)] and ORBIT [C-statistic of 0.56 (95% CI 0.52-0.61)] risk scores had poor discriminative performances in dialysis patients. Furthermore, the calibration analyses showed that patients with a low risk of bleeding according to the HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had higher incidence rates for bleeding in our cohort than predicted. Conclusions The HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had poor predictive abilities in dialysis patients. Therefore, these bleeding risk scores may not be useful in this population.
引用
收藏
页码:1223 / 1231
页数:9
相关论文
共 50 条
  • [41] Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban-treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
    Kline, Jeffrey A.
    Jimenez, David
    Courtney, D. Mark
    Ianus, Juliana
    Cao, Lynn
    Lensing, Anthonie W. A.
    Prins, Martin H.
    Wells, Philip S.
    ACADEMIC EMERGENCY MEDICINE, 2016, 23 (02) : 144 - 150
  • [42] Clinical Performance of Bleeding Risk Scores for Predicting Major and Clinically Relevant Non-Major Bleeding Events in Patients Receiving Oral Anticoagulant Therapy
    Burgess, Sarag
    Crown, Natalie
    Louzada, Martha L.
    Dresser, George
    Kim, Richard
    Lazo-Langner, Alejandro
    BLOOD, 2011, 118 (21) : 1001 - 1002
  • [43] Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores
    Lip, G. Y. H.
    Lane, D. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (09) : 1711 - 1714
  • [44] Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
    Shah, Mitesh
    Tsadok, Meytal Avgil
    Jackevicius, Cynthia A.
    Essebag, Vidal
    Eisenberg, Mark J.
    Rahme, Elham
    Humphries, Karin H.
    Tu, Jack V.
    Behlouli, Hassan
    Guo, Helen
    Pilote, Louise
    CIRCULATION, 2014, 129 (11) : 1196 - 1203
  • [45] GASTROINTESTINAL BLEEDING IN DIALYSIS PATIENTS: IDENTIFYING INCIDENCE, RISK FACTORS AND ENDOSCOPY FINDINGS
    Kumar, A.
    Bachi, B.
    Razaq, H.
    Justice, E. D.
    Yew, A.
    Shivakumar, K.
    GUT, 2016, 65 : A218 - A218
  • [46] Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
    Qureshi, Waqas
    Alirhayim, Zaid
    Khalid, Fatima
    CIRCULATION, 2014, 130 (25) : E427 - E427
  • [47] Utility of Bleeding Risk Scores in Predicting Outcome of Acute Variceal Bleeding
    El Fayoumy, Marwa
    El Tabbakh, Mohammed
    Badra, Gamal
    Rewisha, Eman
    Waked, Imam
    HEPATOLOGY, 2018, 68 : 490A - 490A
  • [48] Bleeding risk-scores for prediction of acute variceal bleeding outcome
    Elfayoumy, Marwa
    Eltabbakh, Mohamed
    Badra, Gamal
    Rewisha, Eman
    Waked, Imam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E638 - E639
  • [49] Upper GI bleeding in dialysis patients
    不详
    MEDICAL JOURNAL OF AUSTRALIA, 2012, 196 (02) : 95 - 95
  • [50] HEMODIALYSIS VERSUS PERITONEAL DIALYSIS AND BLEEDING RISK
    Ocak, Gurbey
    Abrahams, Alferso
    Rookmaaker, Maarten
    Verhaar, Marianne
    Dekker, Friedo
    van Diepen, Merel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33